₹ 279.47 Cr
2.37%
S&P BSE Healthcare TRI
INF966L01CH1
5000.0
1000.0
Sanjeev Sharma, Vasav Sahgal, Sandeep Tandon, Ankit A Pande
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
quant Healthcare Fund - IDCW Option - Regular Plan | - | - | - |
S&P BSE Healthcare TRI | 52.5 | 14.07 | 21.99 |
Equity
Debt
Others
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Company | Holdings (%) |
---|---|
Reliance Industries Ltd. | 9.38 |
Aurobindo Pharma Ltd. | 9.22 |
Poly Medicure Ltd. | 8.75 |
Life Insurance Corporation of India | 8.58 |
Glaxosmithkline Pharmaceuticals Ltd. | 7.91 |
Indraprastha Medical Corporation Ltd. | 6.41 |
Jubilant Pharmova Ltd. | 6.03 |
Kovai Medical Center & Hospital Ltd. | 5.9 |
Gujarat Themis Biosyn Ltd. | 4.77 |
Dishman Carbogen Amcis Ltd. | 4.65 |
Sector | Holdings (%) |
---|---|
Healthcare | 77.97 |
Energy | 9.38 |
Insurance | 8.58 |
Services | 2.95 |
Financial | 1.79 |
N/A | 0.02 |
Others | -0.69 |
Scheme Name | 5Y (%) |
---|---|
quant Healthcare Fund Reg IDCW | 0.0 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.56 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
Mirae Asset Healthcare Reg Gr | 25.04 |
LIC MF Healthcare Fund Reg Gr | 19.52 |